Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27955
Title: Shared Individual Formulation Therapy (SIFT): an open-label trial of a new therapy accommodating patient heterogeneity in functional neurological disorder.
Austin Authors: Gutkin, M;Brown, R J;McLean, L;Streimer, J;Kanaan, Richard A A 
Affiliation: Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia
Division of Psychology and Mental Health, The University of Manchester, Manchester, UK
Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK
Department of Consultation-Liaison Psychiatry, Royal North Shore Hospital, St Leonards, New South Wales, Australia
Psychiatry (University of Melbourne)
Issue Date: Dec-2021
Date: 2021-09-19
Publication information: Journal of Neurology 2021; 268(12): 4882-4889
Abstract: Functional Neurological Disorder (FND) is a complex neuropsychiatric condition with a multifactorial aetiology. The heterogeneity of patients with FND is rarely considered in psychotherapy trials, which may contribute to variable outcomes. Shared Individual Formulation Therapy (SIFT) is a new, brief (four session) psychotherapy that aims to accommodate heterogeneity by providing a personalised, trans-theoretical formulation of the person's difficulties and accompanying management plan. An open-label, prospective trial of outpatient SIFT for adults with FND was conducted, using health-related quality of life (SF-12) as the principal outcome measure, with secondary measures of mental health, dissociation, health care use and attitude to the FND diagnosis. Measures were collected at baseline, end of treatment and 6- and 12-month follow-ups. Twenty-nine participants with various FND symptoms enrolled. Twenty-four completed all four sessions and 25 completed follow-up measures at 12 months. SF-12 scores improved significantly at end of treatment and were sustained throughout follow-up with moderate effect sizes (0.39-0.47; all p < 0.001). Most secondary outcomes also improved significantly at all time points. The intervention was highly acceptable and tolerable to patients and perceived as beneficial. This trial provides preliminary evidence for initial and sustained benefit from SIFT for adults with FND. Further study is needed to validate these findings.
URI: https://ahro.austin.org.au/austinjspui/handle/1/27955
DOI: 10.1007/s00415-021-10797-y
ORCID: 0000-0003-1700-7172
Journal: Journal of Neurology
PubMed URL: 34537867
Type: Journal Article
Subjects: Cognitive behavioural therapy
Conversion disorder
Formulation
Functional neurological disorder
Neuropsychiatry
Psychodynamic therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

20
checked on Jul 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.